NCT05343728View on ClinicalTrials.gov

Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

July 9, 2021

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

Thromboelastography

Thromboelastography was done by using TEG 5000 Hemostasis Analyzer (Haemonetics Corp., USA)

DIAGNOSTIC_TEST

Standard coagulation profile laboratory examination

Standard coagulation profile laboratory examination (platelets, PT/APTT, fibrinogen, and D-dimer) was performed by using Sysmex® CS-2500 and 5100 (Sysmex Corp., Japan)

Trial Locations (1)

10430

Cipto Mangunkusumo Cental National Hospital, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT05343728 - Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19 Patients | Biotech Hunter | Biotech Hunter